DSIP 10mg Strength: 10 mg CAS: 62568-57-4 Chemical Formula: CHNO Molecular weight: 848.8 g/mol Peptide Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu Synonyms: Emideltide, Delta sleep-inducing peptide Storage: Store 28 C (20 C long-term)
However, antimicrobial peptides can also influence intracellular processes through interactions with receptors or signaling molecules and mediate chemotactic or proinflammatory effects
Grade II (moderate / partial tear) Goals Protect the injured ligament while beginning controlled movement Restore ROM Strengthen surrounding muscles Rebuild stability through proprioception Safely progress back to daily/sport use Typical plan Protection / acute phase (first 12 weeks) Use of a hinged knee brace (locked or limited motion) to protect the knee during early healing Crutches if needed (offload to reduce pain) Ice, compression, elevation Pain-free ROM exercises (within brace limits) Gentle muscle activation (quads, hamstrings) Early rehab (weeks 24) Gradually unlock the brace to allow controlled ROM Continue strengthening: seated knee extensions, hamstring curls, calf raises Closed-chain work (mini squats, partial lunges) Proprioceptive drills (balance, single leg stance, wobble pad) Manual therapy / soft tissue techniques on tight muscles Intermediate / loading phase (weeks 46 or more) Increase resistance of strength exercises Dynamic stability (lateral steps, single leg squats) Light jogging when pain and stability allow Sport- or activity-specific drills (cutting, pivoting) Return to sport / full activity (weeks 68+) Strength and hop testing (90 % of uninjured side) Agility, plyometrics, side steps Monitor for symptoms of instability Gradual full return Typically, a Grade II case can take 48 weeks to recover, though more demanding sports may require more time
BPC-157 (5mg-10mg), Body Protection Compound 157 A Pentadecapeptide of Gastric Origin Introduction A Pentadecapeptide of Gastric Origin BPC-157 is a synthetic 15-residue peptide derived from a partial sequence identified within a larger gastric protective protein originally isolated from human gastric juice in the mid-1990s by Sikiric and colleagues at the University of Zagreb
Baek et al , 2020
Scientific interest centers on how the peptide interacts with cellular signaling pathways that researchers commonly examine when modeling tissue maintenance and recovery in experimental systems
